TH
Tekla World Healthcare Fund
THW · NYSE
$13.32 -0.37% (-$0.05)
1M -5.98%
Market Cap $539.8M
P/E Ratio 9.75x
Div. Yield 10.49%
ROE 11.48%
Bulios Fair Price
$15.99
20.0% upside
Current Price
$13.32
Undervalued Fair Value Overvalued
According to Bulios Fair Price, THW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
79 /100
Cheap P/S 8.55x
P/B 1.05x
P/E 9.75x
Growth
76 /100
Growing Book val. growth 4.10%
Rev. growth 18.33%
FCF growth N/A
Profitability
100 /100
Strong Op. margin 87.72%
Net margin 87.72%
FCF margin N/A
Quality
86 /100
Excellent ROA 8.70%
Asset turnover 0.10x
ROE 11.48%
Debt
48 /100
Moderate Current ratio 0.79x
Debt/Assets N/A
Net debt/EBITDA N/A
Stability
33 /100
Unstable Profitable years 3
EPS volatility 111.50%
Beta 0.82x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about THW
Online
Sector
Financial Services
Industry
Asset Management
CEO
William R. Hite
Employees
-
Headquarters
Philadelphia